No abstract available
Keywords:
cisplatin; doxorubicin; multidrug resistance of cancer cells; redox homeostasis, ovarian and breast cancer cells; thioredoxins, peroxiredoxins and thioredoxin reductases.
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics
-
Breast Neoplasms / pathology
-
Cisplatin / pharmacology
-
Cisplatin / therapeutic use
-
Doxorubicin / pharmacology
-
Doxorubicin / therapeutic use
-
Drug Resistance, Multiple / genetics*
-
Drug Resistance, Neoplasm / genetics*
-
Female
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Ovarian Neoplasms / drug therapy*
-
Ovarian Neoplasms / genetics
-
Ovarian Neoplasms / pathology
-
Oxidation-Reduction
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Doxorubicin
-
Cisplatin